Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry (v3.3.3) was added and older items ('HHS Vulnerability Disclosure' and 'Revision: v3.3.2') were removed.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedStudy Status and Recruitment Status were updated to show the trial is Completed, replacing the previous 'Active, not recruiting' status.SummaryDifference0.8%

- Check38 days agoChange DetectedThe notice about government funding and operating status at the top of the page has been removed. This change does not affect the study data or record availability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check59 days agoChange DetectedThe new screenshot shows updates to the Study Status and Recruitment Status in the record history. These changes reflect the trial's current activity and enrollment status.SummaryDifference0.1%

- Check80 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference13%

- Check88 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.